Global Anti-Hypertensive Drugs
Market Report
2024
Anti-Hypertensive Drugs Market Report 2024 (Global Edition)
Global Anti-Hypertensive Drugs market size was USD 29485.8 Million in 2022. Anti-Hypertensive Drugs Industry's Compound Annual Growth Rate will be 3.5% from 2023 to 2030.
The base year for the calculation is 2023 and 2019 to 2023 will be historical period. The year 2024 will be estimated one while the forecasted data will be from year 2025 to 2031. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
|
Rating: 4.8 | Review: 7
Share your contact details to receive free updated sample copy/pages of the recently published edition of Anti-Hypertensive Drugs Market Report 2024.
Global Anti-Hypertensive Drugs Market Report 2024 Market Size Split by Drug Class (Diuretics, ACE Inhibitors, Calcium Channel Blockers, Beta-adrenergic Blockers, Vasodilators, Others), by End User (Re...
Global Anti-Hypertensive Drugs market size was USD 29485.8 Million in 2022. Anti-Hypertensive Drugs Industry's Compound Annual Growth Rate will be 3.5% from 2023 to 2030.
| Base Year | 2023 |
| Historical Data Time Period | 2019-2023 |
| Forecast Period | 2024-2031 |
| Global Anti-Hypertensive Drugs Market Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 3.5% |
| Market Split by Drug Class |
|
| Market Split by End User |
|
| List of Competitors |
|
| Regional Analysis |
|
Country Analysis |
|
Key Qualitative Information Covered |
|
Report scope is customizable as we have a huge database of Anti-Hypertensive Drugs industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Anti-Hypertensive Drugs Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
Anti-Hypertensive Drugs Market Report Description
Introduction of Anti-Hypertensive Drugs
A chronic medical disease known as hypertension is characterized by persistently high blood pressure in the arteries. Patients with high blood pressure, often known as hypertension, are treated with antihypertensive. The increase in the prevalence of hypertension around the world is one of the factors driving the global anti-hypertensive drugs market's expansion. Additionally, a significant element driving the market's expansion is the growing awareness of the risks linked to high blood pressure.
These innovations enable companies to provide more customised products and services, which in turn fuels the expansion of the Anti Hypertensive Drugs market.
- For instance, It is listed as a Non-Government Company with the Chandigarh Registrar of Companies and is registered there. Its authorised share capital is Rs. 3,000,000,000 and its paid up capital is Rs. 2,128,317,440. It is necessary for the creation of other chemical goods.
(Source:www.indiafilings.com/learn/authorised-capital-private-limited-company-registration/)
What is driving the Anti-Hypertensive Drugs Market?
-
Launch of New Disease-Modifying Therapies to Boost Global Antihypertensive Drugs Market
Since anti hypertensive drugs successfully stop the progression of the condition, new antihypertensive medications and pharmacological therapies are anticipated to produce positive results. During the forecast period, new treatments for disorders such angiotensin II receptor blockers (ARBs), angiotensin converting enzyme (ACE) inhibitors, and blockers of calcium channels (CCB) are projected to be introduced, which would modify the current situation in the market for antihypertensive medications.
- Researchers studied the connection between HDI and the prevalence of hypertension. They discovered that it varied between 35 and 41 percent in 182 countries. As a result of the increasing prevalence of hypertension, it is projected that the market for anti-hypertensive medications will expand.
(Source:www.ncbi.nlm.nih.gov/pmc/articles/PMC7444692/)
Nowadays, doctors are prescribing more ACE and CHF inhibitors instead of the usual first-line hypertension medications, beta-blockers and diuretics. Cardiovascular patients who use ACE inhibitors experience a reduction in mortality and morbidity; CCBs do not.
Factors Affecting the Anti-Hypertensive Drugs Industry Growth
-
Low Public Awareness will Limit the Market's Growth for Anti-Hypertensive Drugs
The low level of public awareness of anti-hypertensive medications, particularly in developing countries, is one of the main market limitations. Health exams are frequently neglected, and many people aren't aware they have hypertension until serious symptoms start to show up. Patients who have been diagnosed with hypertension may also not take their medications according to schedule, which can result in low drug adherence and present a big barrier for the market.
COVID-19 Affected the Market for Anti-Hypertensive Drugs
This connection may be explained by particular antihypertensive medications. ACE2—the receptor used by SARS-CoV-2 to enter host cells—may be up-regulated by angiotensin-converting enzyme inhibitors (ACE-Is) and angiotensin II receptor blockers (ARBs), which has been reported to enhance the risk of infection. However, ACE2 may potentially offer protection against a more serious COVID-19 infection by decreasing the effects of angiotensin II.
We have various report editions of Anti-Hypertensive Drugs Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
Anti-Hypertensive Drugs Market Insights Video
Competitive Landscape of Anti-Hypertensive Drugs Market
The market for antihypertensive medications is highly competitive, with a few key players controlling the majority of the industry. Research and development is being funded by several businesses. Among the important tactics used by major players are product portfolio diversification and mergers and acquisitions.
Anti-Hypertensive Drugs Industry News
- June 2020: A co-promotion arrangement for trilaciclib (Cosela), a CDK4/6 inhibitor intended to stop chemotherapy-induced myelosuppression, was announced by Boehringer and G1 Therapeutics. The three-year initial term of the agreement, which focuses on lung cancer of small cells, applies to both the USA and Puerto Rico.
(Source:www.sec.gov/Archives/edgar/data/1560241/000156459021008171/gthx-10k_20201231.html/)
- January 2020: After Enhertu, an antibody-drug conjugate for the treatment of cancer, was approved and released by the U.S. Food and Drug Administration, the company's market value increased to over JPY 5 trillion. Enhertu was created by Daiichi Sankyo in collaboration with AstraZeneca.
(Source:www.daiichisankyo.com/media/press_release/detail/index_3158.html)
- September 2021: Arctos Medical, a gene therapy company, will be acquired by Novartis AG, expanding its optogenetics portfolio. Novartis declared in December that it will pay up to $1.5 billion to acquire Gyroscope Therapeutics from healthcare investment firm Syncona Ltd.
Top Companies Market Share in Anti-Hypertensive Drugs Industry: (In no particular order of Rank)
- Boehringer Ingelheim International GmbH
- Daiichi Sankyo Company Limited
- Novartis AG.
- Sun Pharmaceutical Industries Ltd.
- Ranbaxy Laboratories
- AstraZeneca plc
- Johnson & Johnson
- Pfizer Inc.
- Lupin
- Merck & Co. Inc
- SANOFI
- Confidential Data
- Access The Paid Version
- Data Hidden
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
The North America Anti-Hypertensive Drugs Market dominates the global market in 2022!
Due to a number of factors, North America controlled the market in 2022 and contributed more than 35% of the global revenue, according to Cognitive Market Research. The Anti Hypertensive Drugs market is dominated by the North American continent. North America now controls a sizable portion of the global market for anti-hypertensive medications due to a high incidence of both the disorders that cause it and the hypertension itself in the region. Over the forecast term, it is expected to display a similar trend. Other significant market factors for the anti-hypertension market in North America include the need for quick and accurate hypertension diagnosis and treatment, identifying those at risk for the disorder, the presence of in technology advanced healthcare infrastructure, and controlling the disease's prognosis. The United States is expected to hold a strong position in the North American region, according to Cognitive Market Research, because of its huge economic heft, extensive worldwide corporate presence, and diverse population. Due to a growth in the number of instances of hypertension in this area, there is a great demand for anti-hypertensive medications. Sedentary lifestyles, increasing junk food intake, a lack of a balanced diet, and insufficient sleep as a result of unpredictable work schedules all contribute to this requirement.
Strong economic growth in the area and a sizable presence of multinational corporations result in a high demand for anti-hypertensive medications, which fosters international trade and corporate expansion. In July 2022, there will be 116 million adults, or 47% of the population, who have hypertension, according to the Centres for Disease Control and Prevention. The increased frequency of hypertension in the US is therefore anticipated to enhance demand for anti-hypertensive drugs, which would propel market expansion.
The current report Scope analyzes Anti-Hypertensive Drugs Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
- North America (United States, Canada, Mexico)
- Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
- Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
- South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
- Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)
Anti-Hypertensive Drugs Market Share (%) by Region (2019-2031)
The above graph is for illustrative purposes only.
To learn more about geographical trends request the free sample pages.
Get Free Sample
Anti-Hypertensive Drugs Market Analysis
Global Anti-Hypertensive Drugs Market Report 2024 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Anti-Hypertensive Drugs Industry growth. Anti-Hypertensive Drugs market has been segmented with the help of its Drug Class, End User , and others. Anti-Hypertensive Drugs market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
By Drug Class, the Calcium Channel Blockers segment has quickest growth in Anti-Hypertensive Drugs Market!
According to Cognitive Market Research, ACE inhibitors are the product that is used the most commonly in the market for anti-hypertensive drugs. The most popular way to deliver ACE inhibitors is orally, however, intravenous variants are also available. The prefix "-pril" is most frequently found at the end of these drugs. Lisinopril, ramipril, and captopril are among examples. ACE inhibitors are a class of drugs that are used to treat and manage hypertension, which is a major risk factor for heart disease, stroke, heart failure, and several other cardiovascular disorders. Most instances are primary and have no known aetiology.
The industry in this market with the quickest growth is calcium channel blockers. While sharing the same capacity to interact with l-type voltage-dependent transmembrane calcium channels, CCBs within the drug class shown a number of significant differences from the pharmacokinetic and pharmacodynamic points of view, as well as for selectivity and duration of pharmacological effect. As can be predicted, these variations affect the therapeutic and clinical efficacy as well as the tolerability and safety profile in various clinical situations.
- Diuretics
- ACE Inhibitors
- Calcium Channel Blockers
- Beta-adrenergic Blockers
- Vasodilators
- Others
Anti-Hypertensive Drugs Market Share (%) by Drug Class in 2019-2031
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Anti-Hypertensive Drugs Industry. Request a Free Sample PDF!
By End User, the Retail Pharmacy segment accounted for the greatest market share of Anti-Hypertensive Drugs Market!
In 2022, the retail pharmacies category accounted for the greatest market share. The rapid adoption of retail pharmacies, which has increased patient satisfaction, is responsible for this expansion. Retail pharmacy may carry antihypertensive drugs like thiazide diuretics. Pharmacists are better able to advise patients on safe application when they have access to complete patient histories, which include the experts they sought out, the medications they used, and more. Collaboration may help reduce outpatient medication errors, which are a significant risk when patients hop from pharmacy to pharmacy after receiving a prescription. Therefore, the expansion of this market is being further fueled by the care team's collaboration to improve patient outcomes.
The second-most popular industry in this market, based on Cognitive Market Research, is hospital pharmacies. To diversify their revenue streams, hospital pharmacists are expanding access to the most illegal medications. Furthermore, the medications are regularly prescribed, and their prescriptions are typically written by trained healthcare specialists and are available in hospitals. The market popularity of this segment is increasing, and this is a key factor in that expansion.
- Retail Pharmacy
- Hospital Pharmacy
- E-commerce Websites & Online Drug Stores
Anti-Hypertensive Drugs Market Share (%) by End User in 2019-2031
2019
2023
2031
The above Graph is for representation purposes only. This chart does not depict actual Market share.
To learn more about market share request the free sample pages.
Get Free Sample
Author's Detail
Manjiri KanhereSenior Research Associate at Cognitive Market Research
Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.
Bio :
Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over three years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies.
In her current role, Manjiri handles the market research related to Pharma and healthcare industry. Her passion lies in utilizing innovative approaches to distill complex information into strategic insights that empower organizations to make informed decisions.Manjiri remains an invaluable asset in the dynamic landscape of market research.
Author's Conclusion
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Global Anti-Hypertensive Drugs Market is witnessing significant growth in the near future.
In 2023, the Diuretics segment accounted for noticeable share of global Anti-Hypertensive Drugs Market and is projected to experience significant growth in the near future.
The Retail Pharmacy segment is expected to expand at the significant CAGR retaining position throughout the forecast period.
Some of the key companies Boehringer Ingelheim International GmbH , Novartis AG. and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the global market.
Frequently Asked Questions (FAQs)
The anti hypertensive drugs market was estimated to be worth 29485.8 USD million globally in 2022.
During the forecast period, the global market is anticipated to expand at a CAGR of 3.50%.
In 2022, North America accounted for the biggest revenue share of the global market for antihypertensive drugs.
In the upcoming years, Asia Pacific will have the market's fastest growth for antihypertensive medications worldwide.
In 2022, the United States held the biggest revenue share in the global market for antihypertensive medications.
The availability of potential products and the introduction of new disease-modifying therapies are the primary factors driving the expansion of the anti-hypertensive drug market.
According to drug class, the ACE Inhibitors category had the biggest market share worldwide.
In terms of end users, the retail pharmacy sector had an important share of revenue in the worldwide market in 2022.
Anti-Hypertensive Drugs market size was USD 29485.8 Million in 2022. Anti-Hypertensive Drugs Industry's Compound Annual Growth Rate will be 3.5% from 2023 to 2030.
Please note, we have not disclose, all the sources consulted/referred during a market study due to confidentiality and paid service concern. However, rest assured that upon purchasing the service or paid report version, we will release the comprehensive list of sources along with the complete report and we also provide the data support where you can intract with the team of analysts who worked on the report.
Latest News about Anti-Hypertensive Drugs Market
Latest Articles about Anti-Hypertensive Drugs Market
A chronic medical disease known as hypertension is characterised by persistently high blood pressure in the arteries. Patients with high blood pressure, often known as hypertension, are treated with antihypertensive. The increase in the prevalence of hypertension around the world is one of the factors driving the global antihypertensive medicines market's expansion.
Sources from Pharma & Healthcare Industry
- https://en.wikipedia.org/wiki/American_Society_for_Pharmacy_Law
- https://en.wikipedia.org/wiki/American_Society_of_Consultant_Pharmacists
- https://en.wikipedia.org/wiki/American_Society_of_Health-System_Pharmacists
- https://www.apsm-uk.com/
- https://en.wikipedia.org/wiki/Australasian_College_of_Pharmacy
- https://en.wikipedia.org/wiki/American_Association_of_Colleges_of_Pharmacy
- https://en.wikipedia.org/wiki/American_College_of_Clinical_Pharmacy
- https://en.wikipedia.org/wiki/American_Pharmacists_Association
- https://www.bio.org/
- https://en.wikipedia.org/wiki/Canadian_Pharmacists_Association
- https://en.wikipedia.org/wiki/Canadian_Society_of_Hospital_Pharmacists
- https://en.wikipedia.org/wiki/Chinese_Pharmaceutical_Association
- https://en.wikipedia.org/wiki/American_Association_of_Psychiatric_Pharmacists
- https://en.wikipedia.org/wiki/Danish_Association_of_Pharmaconomists
- https://en.wikipedia.org/wiki/EPhEU
- https://www.fda.gov/
- https://www.gmc-uk.org/
- https://www.ifpma.org/
- https://www.fip.org/
- https://en.wikipedia.org/wiki/International_Pharmaceutical_Students%27_Federation
- https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency
- https://en.wikipedia.org/wiki/National_Pharmacy_Association
- https://en.wikipedia.org/wiki/Norwegian_Pharmacy_Association
- https://en.wikipedia.org/wiki/Canadian_Pharmacists_Journal#History
- https://en.wikipedia.org/wiki/Pakistan_Pharmacists_Association
- https://en.wikipedia.org/wiki/Pharmaceutical_Association_of_Mauritius
- https://en.wikipedia.org/wiki/Pharmaceutical_Group_of_the_European_Union
- https://en.wikipedia.org/wiki/Pharmaceutical_Society_of_Australia
- https://en.wikipedia.org/wiki/Pharmaceutical_Society_of_New_Zealand
- https://en.wikipedia.org/wiki/Pharmaceutical_Society_of_Northern_Ireland
- https://en.wikipedia.org/wiki/Professional_Compounding_Centers_of_America
- https://en.wikipedia.org/wiki/Royal_Pharmaceutical_Society
- https://www.aaps.org/home
- https://www.bioindustry.org/
- https://www.controlledreleasesociety.org/
- https://www.efpia.eu/
- https://www.epemed.org/online/www/content/ENG/index.html
- https://icr-global.org/
- https://ispe.org/
- https://en.wikipedia.org/wiki/Pharmaceutical_Association_of_Israel
- https://www.phrma.org/
- https://en.wikipedia.org/wiki/The_Pharmacy_Guild_of_Australia
- https://en.wikipedia.org/wiki/The_Society_of_Hospital_Pharmacists_of_Australia
- https://en.wikipedia.org/wiki/Healthcare_industry
- https://www.pharma-iq.com/business-development/articles/top-50-pharmaceutical-blogs-and-publications
- https://www.pharmatimes.com/news
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7967517/
- https://www.cbo.gov/publication/57126
- http://: https://www.who.int/tools/atc-ddd-toolkit/data
- https://www.oecd.org/els/health-systems/health-data.htm
- https://www.bls.gov/ooh/healthcare/home.htm
- https://data.worldbank.org/topic/8
- https://www.statnews.com/about/
- https://www.health.pa.gov/topics/HealthStatistics/Pages/health-statistics.aspx
- https://ec.europa.eu/eurostat/statistics-explained/index.php?title=Healthcare_expenditure_statistics
- https://www.cdc.gov/nchs/index.htm
- https://www.aha.org/statistics/fast-facts-us-hospitals
- https://www.census.gov/library/publications/2021/demo/p60-274.html
- https://www.adb.org/what-we-do/sectors/health/main
Anti-Hypertensive Drugs Market Report Table of Content
Disclaimer:
- This is just a redacted sample pages of the actual deliverable report and only for representative purposes
- Charts/Graphs/Numbers/data are only for Representative purposes and do not depict actual statistics.
- The table of Contents differs according to the user License selection. Current Displayed TOC is for the Corporate User License Report Edition. TOC Customization options: Add or Remove section/s Or chapter/s from the report.
- Specific Tables, Graphs, Sections, and Chapters can be ordered at a discounted price.
- If applicable; On Request Volume Data will also be provided (at an Additional Cost).
| Drug Class | Diuretics, ACE Inhibitors, Calcium Channel Blockers, Beta-adrenergic Blockers, Vasodilators, Others |
| End User | Retail Pharmacy, Hospital Pharmacy, E-commerce Websites & Online Drug Stores |
| List of Competitors | Boehringer Ingelheim International GmbH, Daiichi Sankyo Company Limited, Novartis AG., Sun Pharmaceutical Industries Ltd., Ranbaxy Laboratories, AstraZeneca plc, Johnson & Johnson, Pfizer Inc., Lupin, Merck & Co. Inc, SANOFI |
Expand All
This chapter will help you gain GLOBAL Market Analysis of Anti-Hypertensive Drugs. Further deep in this chapter, you will be able to review Global Anti-Hypertensive Drugs Market Split by various segments and Geographical Split.
Chapter 1 Global Market Analysis
-
1.1 Global Anti-Hypertensive Drugs Market Size, Trend Analysis 2019 - 2031
-
1.2 Global Anti-Hypertensive Drugs Market Size By Regions 2019 - 2031
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
-
1.2.1 Global Anti-Hypertensive Drugs Revenue Market Size By Region
-
-
1.3 Global Anti-Hypertensive Drugs Market Size By Drug Class 2019 -2031
-
1.3.1 Diuretics Market Size
-
1.3.2 ACE Inhibitors Market Size
-
1.3.3 Calcium Channel Blockers Market Size
-
1.3.4 Beta-adrenergic Blockers Market Size
-
1.3.5 Vasodilators Market Size
-
1.3.6 Others Market Size
-
-
1.4 Global Anti-Hypertensive Drugs Market Size By End User 2019 -2031
-
1.4.1 Retail Pharmacy Market Size
-
1.4.2 Hospital Pharmacy Market Size
-
1.4.3 E-commerce Websites & Online Drug Stores Market Size
-
-
1.5 Global Level Competitor Analysis (Subject to Data Availability (Private Players))
-
1.6 Executive Summary Global Market (2019 vs 2024 vs 2031)
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
-
1.6.1 Regional Market Revenue Summary 2019 vs 2024 vs 2031
-
1.6.2 Global Market Revenue Split By Drug Class
-
1.6.3 Global Market Revenue Split By End User
-
1.6.4 Global Market Dynamics, Trends, Drivers, Restraints, Opportunities
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
-
Chapter 2 North America Market Analysis
-
2.1 North America Anti-Hypertensive Drugs Market Size 2019 - 2031
-
2.1.1 North America Anti-Hypertensive Drugs Market Size By Country 2019 - 2031
-
2.1.2 North America Anti-Hypertensive Drugs Market Size by Drug Class 2019 -2031
-
2.1.2.1 North America Diuretics Market Size
-
2.1.2.2 North America ACE Inhibitors Market Size
-
2.1.2.3 North America Calcium Channel Blockers Market Size
-
2.1.2.4 North America Beta-adrenergic Blockers Market Size
-
2.1.2.5 North America Vasodilators Market Size
-
2.1.2.6 North America Others Market Size
-
-
2.1.3 North America Anti-Hypertensive Drugs Market Size by End User 2019 -2031
-
2.1.3.1 North America Retail Pharmacy Market Size
-
2.1.3.2 North America Hospital Pharmacy Market Size
-
2.1.3.3 North America E-commerce Websites & Online Drug Stores Market Size
-
-
Chapter 3 Europe Market Analysis
-
3.1 Europe Anti-Hypertensive Drugs Market Size 2019 - 2031
-
3.1.1 Europe Anti-Hypertensive Drugs Market Size By Country 2019 - 2031
-
3.1.2 Europe Anti-Hypertensive Drugs Market Size by Drug Class 2019 -2031
-
3.1.2.1 Europe Diuretics Market Size
-
3.1.2.2 Europe ACE Inhibitors Market Size
-
3.1.2.3 Europe Calcium Channel Blockers Market Size
-
3.1.2.4 Europe Beta-adrenergic Blockers Market Size
-
3.1.2.5 Europe Vasodilators Market Size
-
3.1.2.6 Europe Others Market Size
-
-
3.1.3 Europe Anti-Hypertensive Drugs Market Size by End User 2019 -2031
-
3.1.3.1 Europe Retail Pharmacy Market Size
-
3.1.3.2 Europe Hospital Pharmacy Market Size
-
3.1.3.3 Europe E-commerce Websites & Online Drug Stores Market Size
-
-
Chapter 4 Asia Pacific Market Analysis
-
4.1 Asia Pacific Anti-Hypertensive Drugs Market Size 2019 - 2031
-
4.1.1 Asia Pacific Anti-Hypertensive Drugs Market Size By Country 2019 - 2031
-
4.1.2 Asia Pacific Anti-Hypertensive Drugs Market Size by Drug Class 2019 -2031
-
4.1.2.1 Asia Pacific Diuretics Market Size
-
4.1.2.2 Asia Pacific ACE Inhibitors Market Size
-
4.1.2.3 Asia Pacific Calcium Channel Blockers Market Size
-
4.1.2.4 Asia Pacific Beta-adrenergic Blockers Market Size
-
4.1.2.5 Asia Pacific Vasodilators Market Size
-
4.1.2.6 Asia Pacific Others Market Size
-
-
4.1.3 Asia Pacific Anti-Hypertensive Drugs Market Size by End User 2019 -2031
-
4.1.3.1 Asia Pacific Retail Pharmacy Market Size
-
4.1.3.2 Asia Pacific Hospital Pharmacy Market Size
-
4.1.3.3 Asia Pacific E-commerce Websites & Online Drug Stores Market Size
-
-
Chapter 5 South America Market Analysis
-
5.1 South America Anti-Hypertensive Drugs Market Size 2019 - 2031
-
5.1.1 South America Anti-Hypertensive Drugs Market Size By Country 2019 - 2031
-
5.1.2 South America Anti-Hypertensive Drugs Market Size by Drug Class 2019 -2031
-
5.1.2.1 South America Diuretics Market Size
-
5.1.2.2 South America ACE Inhibitors Market Size
-
5.1.2.3 South America Calcium Channel Blockers Market Size
-
5.1.2.4 South America Beta-adrenergic Blockers Market Size
-
5.1.2.5 South America Vasodilators Market Size
-
5.1.2.6 South America Others Market Size
-
-
5.1.3 South America Anti-Hypertensive Drugs Market Size by End User 2019 -2031
-
5.1.3.1 South America Retail Pharmacy Market Size
-
5.1.3.2 South America Hospital Pharmacy Market Size
-
5.1.3.3 South America E-commerce Websites & Online Drug Stores Market Size
-
-
Chapter 6 Middle East and Africa Market Analysis
-
6.1 Middle East and Africa Anti-Hypertensive Drugs Market Size 2019 - 2031
-
6.1.1 Middle East and Africa Anti-Hypertensive Drugs Market Size By Country 2019 - 2031
-
6.1.2 Middle East and Africa Anti-Hypertensive Drugs Market Size by Drug Class 2019 -2031
-
6.1.2.1 Middle East and Africa Diuretics Market Size
-
6.1.2.2 Middle East and Africa ACE Inhibitors Market Size
-
6.1.2.3 Middle East and Africa Calcium Channel Blockers Market Size
-
6.1.2.4 Middle East and Africa Beta-adrenergic Blockers Market Size
-
6.1.2.5 Middle East and Africa Vasodilators Market Size
-
6.1.2.6 Middle East and Africa Others Market Size
-
-
6.1.3 Middle East and Africa Anti-Hypertensive Drugs Market Size by End User 2019 -2031
-
6.1.3.1 middle_east_and_africa_title} Retail Pharmacy Market Size
-
6.1.3.2 middle_east_and_africa_title} Hospital Pharmacy Market Size
-
6.1.3.3 middle_east_and_africa_title} E-commerce Websites & Online Drug Stores Market Size
-
-
Only Available with Corporate User License
Chapter 7 Top 10 Countries Analysis (Only Available with Corporate User License)
-
7.1 Country 1 Market Analysis
-
7.1.1 Country 1Anti-Hypertensive Drugs Market Size by Drug Class 2019 -2031
-
7.1.2 Country 1Anti-Hypertensive Drugs Market Size by End User 2019 -2031
-
-
7.2 Country 2 Market Analysis
-
7.2.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.3 Country 3 Market Analysis
-
7.3.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.4 Country 4 Market Analysis
-
7.4.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.5 Country 5 Market Analysis
-
7.5.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.6 Country 6 Market Analysis
-
7.6.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.7 Country 7 Market Analysis
-
7.7.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.8 Country 8 Market Analysis
-
7.8.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.9 Country 9 Market Analysis
-
7.9.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.10 Country 10 Market Analysis
-
7.10.1 Segmentation Analysis will be provided as shown for Country 1
-
Competitor's Market Share and Revenue (Subject to Data Availability for Private Players)
Chapter 8 Competitor Analysis (Subject to Data Availability (Private Players))
-
8.1 Top Competitors Analysis
-
8.1.1 Top Players Ranking 2022
-
8.1.2 Global Anti-Hypertensive Drugs Market Revenue and Share by Manufacturers (2019-2023)
(Subject to Data Availability (Private Players))
-
8.1.3 Industry Mergers and Acquisition Analysis
-
8.1.4 New Product Launch Analysis
-
-
8.2 Company Profile (Data Subject to Availability)
-
8.2.1 Boehringer Ingelheim International GmbH
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.1.2 Business Overview
-
8.2.1.3 Financials (Subject to data availability)
-
8.2.1.4 Product Types Specification
-
8.2.1.5 Business Strategy
-
8.2.1.6 S.W.O.TAnalysis
-
-
8.2.2 Daiichi Sankyo Company Limited
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.2.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.2.2 Business Overview
-
8.2.2.3 Financials (Subject to data availability)
-
8.2.2.4 Product Types Specification
-
8.2.2.5 Business Strategy
-
8.2.2.6 S.W.O.TAnalysis
-
-
8.2.3 Novartis AG.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.3.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.3.2 Business Overview
-
8.2.3.3 Financials (Subject to data availability)
-
8.2.3.4 Product Types Specification
-
8.2.3.5 Business Strategy
-
8.2.3.6 S.W.O.TAnalysis
-
-
8.2.4 Sun Pharmaceutical Industries Ltd.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.4.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.4.2 Business Overview
-
8.2.4.3 Financials (Subject to data availability)
-
8.2.4.4 Product Types Specification
-
8.2.4.5 Business Strategy
-
8.2.4.6 S.W.O.TAnalysis
-
-
8.2.5 Ranbaxy Laboratories
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.5.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.5.2 Business Overview
-
8.2.5.3 Financials (Subject to data availability)
-
8.2.5.4 Product Types Specification
-
8.2.5.5 Business Strategy
-
8.2.5.6 S.W.O.TAnalysis
-
-
8.2.6 AstraZeneca plc
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.6.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.6.2 Business Overview
-
8.2.6.3 Financials (Subject to data availability)
-
8.2.6.4 Product Types Specification
-
8.2.6.5 Business Strategy
-
8.2.6.6 S.W.O.TAnalysis
-
-
8.2.7 Johnson & Johnson
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.7.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.7.2 Business Overview
-
8.2.7.3 Financials (Subject to data availability)
-
8.2.7.4 Product Types Specification
-
8.2.7.5 Business Strategy
-
8.2.7.6 S.W.O.TAnalysis
-
-
8.2.8 Pfizer Inc.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.8.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.8.2 Business Overview
-
8.2.8.3 Financials (Subject to data availability)
-
8.2.8.4 Product Types Specification
-
8.2.8.5 Business Strategy
-
8.2.8.6 S.W.O.TAnalysis
-
-
8.2.9 Lupin
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.9.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.9.2 Business Overview
-
8.2.9.3 Financials (Subject to data availability)
-
8.2.9.4 Product Types Specification
-
8.2.9.5 Business Strategy
-
8.2.9.6 S.W.O.TAnalysis
-
-
8.2.10 Merck & Co. Inc
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.10.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.10.2 Business Overview
-
8.2.10.3 Financials (Subject to data availability)
-
8.2.10.4 Product Types Specification
-
8.2.10.5 Business Strategy
-
8.2.10.6 S.W.O.TAnalysis
-
-
8.2.11 SANOFI
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.11.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.11.2 Business Overview
-
8.2.11.3 Financials (Subject to data availability)
-
8.2.11.4 Product Types Specification
-
8.2.11.5 Business Strategy
-
8.2.11.6 S.W.O.TAnalysis
-
-
Chapter 9 Qualitative Analysis (Subject to Data Availability)
-
9.1 Market Drivers
-
9.2 Market Trends
-
9.3 Market Restraints
-
9.4 Market Opportunity
-
9.5 Product Life Cycle (Subject to Data Availability)
-
9.6 Industrial Chain Analysis (Subject to Data Availability)
-
9.6.1 Industry Chain Analysis
-
9.6.2 Manufacturing Cost Analysis
-
9.6.3 Consumer Preference Analysis
-
9.6.4 Supply Side Analysis
-
9.6.4.1 Raw Material Analysis
-
9.6.4.2 Raw Material Procurement Analysis
-
9.6.4.3 Raw Material Price Trend Analysis
-
-
-
9.7 Market Attractiveness Analysis
-
9.8 PESTEL Analysis
-
9.9 Porter’s Five Forces Analysis
-
9.10 Patent Analysis (Subject to Data Availability)
-
9.11 ESG Analysis
-
9.12 Technological Road Map
Segmentation Drug Class Analysis 2019 -2031, will provide market size split by Drug Class. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 10 Market Split by Drug Class Analysis 2019 -2031
-
10.1 Diuretics
-
10.1.1 Global Anti-Hypertensive Drugs Revenue Market Size and Share by Diuretics 2019 -2031
-
-
10.2 ACE Inhibitors
-
10.2.1 Global Anti-Hypertensive Drugs Revenue Market Size and Share by ACE Inhibitors 2019 -2031
-
-
10.3 Calcium Channel Blockers
-
10.3.1 Global Anti-Hypertensive Drugs Revenue Market Size and Share by Calcium Channel Blockers 2019 -2031
-
-
10.4 Beta-adrenergic Blockers
-
10.4.1 Global Anti-Hypertensive Drugs Revenue Market Size and Share by Beta-adrenergic Blockers 2019 -2031
-
-
10.5 Vasodilators
-
10.5.1 Global Anti-Hypertensive Drugs Revenue Market Size and Share by Vasodilators 2019 -2031
-
-
10.6 Others
-
10.6.1 Global Anti-Hypertensive Drugs Revenue Market Size and Share by Others 2019 -2031
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 11 Market Split by End User Analysis 2019 -2031
-
11.1 Retail Pharmacy
-
11.1.1 Global Anti-Hypertensive Drugs Revenue Market Size and Share by Retail Pharmacy 2019 - 2031
-
-
11.2 Hospital Pharmacy
-
11.2.1 Global Anti-Hypertensive Drugs Revenue Market Size and Share by Hospital Pharmacy 2019 - 2031
-
-
11.3 E-commerce Websites & Online Drug Stores
-
11.3.1 Global Anti-Hypertensive Drugs Revenue Market Size and Share by E-commerce Websites & Online Drug Stores 2019 - 2031
-
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Anti-Hypertensive Drugs market
Chapter 12 Research Findings
-
12.1 Key Takeaways
-
12.2 Analyst Point of View
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
-
12.3 Assumptions and Acronyms
Sample Format of Deliverables
The Tables, Graphs/Charts are only for representative purposes and do not depict actual statistics. Purchase full Report access to actual data.
Qualitative Analysis
Market Timeline 2019 till 2031, Market Size, Revenue/Volume Share, Forecast and CAGR, Competitor Analysis, Regional Analysis, Country Analysis, Segment Analysis, Market Trends, Drivers, Opportunities, Restraints, ESG Analysis, Porters Analysis, PESTEL Analysis, Market Attractiveness, Patent Analysis, Technological Trend, SWOT Analysis, COVID-19 Analysis, Consumer Behavior Analysis, etc.
Market Timeline 2019 till 2031, Market Size, Revenue/Volume Share, Forecast and CAGR, Competitor Analysis, Regional Analysis, Country Analysis, Segment Analysis, Market Trends, Drivers, Opportunities, Restraints, ESG Analysis, Porters Analysis, PESTEL Analysis, Market Attractiveness, Patent Analysis, Technological Trend, SWOT Analysis, COVID-19 Analysis, Consumer Behavior Analysis, etc.
Research Methodology Implemented by Manjiri Kanhere and Team
- 1.1 Anti-Hypertensive Drugs Market Report 2024 Research Methodology
- 1.2 Systematic Research Approach
- 1.2.1 Primary Research for Anti-Hypertensive Drugs Market
- 1.2.1.1 Key Data from Primary
- 1.2.1.2 Primary Interviews with Experts
- 1.2.1.3 Key Industry Insights
- 1.2.1.4 Questionnaire for Anti-Hypertensive Drugs Market
- 1.2.1.5 Breakdown of Primaries
- 1.2.2 Secondary Research for Anti-Hypertensive Drugs Market
- 1.2.2.1 Key Data from Secondary
- 1.2.2.2 Paid Sources
- 1.2.2.3 Public Sources
- 1.3 Market Size Estimation for Anti-Hypertensive Drugs Market
- 1.3.1 Top-Down Approach
- 1.3.1.1 Analyzing Market Size by Top-Down Approach (Supply Side)
- 1.3.2 Bottom-UP Approach
- 1.3.2.1 Analyzing Market Size by Bottom-Up Approach (Demand Side)
- 1.3.1 Top-Down Approach
- 1.4 Market Breakdown and Data Triangulation
- 1.5 Research Assumptions for Anti-Hypertensive Drugs Market
Key Questions Answered By Anti-Hypertensive Drugs Market Report 2024
| Why Diuretics have a significant impact on Anti-Hypertensive Drugs market? |
| What are the key factors affecting the Diuretics and ACE Inhibitors of Anti-Hypertensive Drugs Market? |
| What is the CAGR/Growth Rate of Retail Pharmacy during the forecast period? |
| By type, which segment accounted for largest share of the global Anti-Hypertensive Drugs Market? |
| Which region is expected to dominate the global Anti-Hypertensive Drugs Market within the forecast period? |
| Segmentation Level Customization |
|
| Global level Data Customization |
|
| Region level Data Customization |
|
| Country level Data Customization |
|
| Company Level |
|
| Additional Data Analysis |
|
| Additional Qualitative Data |
|
| Additional Quantitative Data |
|
| Service Level Customization |
|
Report Format Alteration |
|
